Fish oil supplementation of maternal rats on an n-3 fatty acid-deficient diet prevents depletion of maternal brain regional docosahexaenoic acid levels and has a postpartum anxiolytic effect

Journal of Nutritional Biochemistry

Volumn 23, Issue 3, 2012, Pages 299-305

  Chen, Hui Feng ^a   Su, Hui Min ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Anxiety; Arachidonic acid; Docosahexaenoic acid; Fish oil; Reproductive cycle; Serotonin

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; DOCOSAHEXAENOIC ACID; FISH OIL; POLYUNSATURATED FATTY ACID; SEROTONIN; SUNFLOWER OIL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANXIETY; ARTICLE; BRAIN STEM; CEREBELLUM; DIET SUPPLEMENTATION; DIET THERAPY; ENERGY RESOURCE; ERYTHROCYTE; FEMALE; FRONTAL CORTEX; HIPPOCAMPUS; HYPOTHALAMUS; LACTATION; LIPID COMPOSITION; LIPID DIET; NEUROMODULATION; NONHUMAN; NUTRITIONAL ASSESSMENT; NUTRITIONAL STATUS; OLFACTORY BULB; OVARY CYCLE; PREGNANCY; PUERPERIUM; RAT; RETINA; SEROTONIN METABOLISM;

ANIMALS; ANTI-ANXIETY AGENTS; BRAIN; BREAST FEEDING; DIET; DIETARY SUPPLEMENTS; DOCOSAHEXAENOIC ACIDS; FEMALE; FISH OILS; LACTATION; MILK; PLANT OILS; POSTPARTUM PERIOD; PREGNANCY; RATS; RATS, SPRAGUE-DAWLEY; REPRODUCTION;

HELIANTHUS; HIPPOCAMPUS (FISH); RATTUS;

EID: 84856708210     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2010.12.010     Document Type: Article

References (41)

1. Sastry P.S. Lipids of nervous tissue: composition and metabolism. Prog Lipid Res 1985, 24(2):69-176.
2. Dobbing J., Sands J. Comparative aspects of the brain growth spurt. Early Hum Dev 1979, 3(1):79-83.
3. Green P., Glozman S., Kamensky B., Yavin E. Developmental changes in rat brain membrane lipids and fatty acids. The preferential prenatal accumulation of docosahexaenoic acid. J Lipid Res 1999, 40(5):960-966.
4. Martinez M. Tissue levels of polyunsaturated fatty acids during early human development. J Pediatr 1992 Apr, 120(4 Pt 2):S129-138.
5. Fedorova I., Salem N. Omega-3 fatty acids and rodent behavior. Prostaglandins Leukot Essent Fatty Acids 2006, 75(4-5):271-289.
6. Innis S.M. Essential fatty acids in growth and development. Prog Lipid Res 1991, 30(1):39-103.
7. Salem N., Litman B., Kim H.Y., Gawrisch K. Mechanisms of action of docosahexaenoic acid in the nervous system. Lipids 2001, 36(9):945-959.
8. Levant B., Radel J.D., Carlson S.E. Reduced brain DHA content after a single reproductive cycle in female rats fed a diet deficient in N-3 polyunsaturated fatty acids. Biol Psychiatry 2006, 60(9):987-990.
9. Levant B., Ozias M.K., Carlson S.E. Diet (n-3) polyunsaturated fatty acid content and parity interact to alter maternal rat brain phospholipid fatty acid composition. J Nutr 2006, 136(8):2236-2242.
10. Levant B., Ozias M.K., Carlson S.E. Specific brain regions of female rats are differentially depleted of docosahexaenoic acid by reproductive activity and an (n-3) fatty acid-deficient diet. J Nutr 2007, 137(1):130-134.
11. Wenzel A., Haugen E.N., Jackson L.C., Brendle J.R. Anxiety symptoms and disorders at eight weeks postpartum. J Anxiety Disord 2005, 19(3):295-311.
12. Ross L.E., McLean L.M. Anxiety disorders during pregnancy and the postpartum period: a systematic review. J Clin Psychiatry 2006, 67(8):1285-1298.
13. Stuart S., Couser G., Schilder K., O'Hara M.W., Gorman L. Postpartum anxiety and depression: onset and comorbidity in a community sample. J Nerv Ment Dis 1998, 186(7):420-424.
14. Ressler K.J., Nemeroff C.B. Role of serotonergic and noradrenergic systems in the pathophysiology of depression and anxiety disorders. Depress Anxiety 2000, 12(Suppl 1):2-19.
15. Moses-Kolko E.L., Bogen D., Perel J., Bregar A., Uhl K., Levin B., et al. Neonatal signs after late in utero exposure to serotonin reuptake inhibitors: literature review and implications for clinical applications. JAMA 2005, 293(19):2372-2383.
16. Freeman M.P., Hibbeln J.R., Wisner K.L., Davis J.M., Mischoulon D., Peet M., et al. Omega-3 fatty acids: evidence basis for treatment and future research in psychiatry. J Clin Psychiatry 2006, 67(12):1954-1967.
17. Parker G., Gibson N.A., Brotchie H., Heruc G., Rees A.M., Hadzi-Pavlovic D. Omega-3 fatty acids and mood disorders. Am J Psychiatry 2006, 163(6):969-978.
18. Bourre J.M., Francois M., Youyou A., Dumont O., Piciotti M., Pascal G., et al. The effects of dietary alpha-linolenic acid on the composition of nerve membranes, enzymatic activity, amplitude of electrophysiological parameters, resistance to poisons and performance of learning tasks in rats. J Nutr 1989, 119(12):1880-1892.
19. Bligh E.G., Dyer W.J. A rapid method of total lipid extraction and purification. Can J Biochem Physiol 1959, 37(8):911-917.
20. Moser A.B., Jones D.S., Raymond G.V., Moser H.W. Plasma and red blood cell fatty acids in peroxisomal disorders. Neurochem Res 1999, 24(2):187-197.
21. Chung W.L., Chen J.J., Su H.M. Fish oil supplementation of control and (n-3) fatty acid-deficient male rats enhances reference and working memory performance and increases brain regional docosahexaenoic acid levels. J Nutr 2008, 138(6):1165-1171.
22. Shih J.C., Chen K., Ridd M.J. Role of MAO A and B in neurotransmitter metabolism and behavior. Pol J Pharmacol 1999, 51(1):25-29.
23. Mathews T.A., Fedele D.E., Coppelli F.M., Avila A.M., Murphy D.L., Andrews A.M. Gene dose-dependent alterations in extraneuronal serotonin but not dopamine in mice with reduced serotonin transporter expression. J Neurosci Methods 2004, 140(1-2):169-181.
24. Bourre J.M., Dumont O.S., Piciotti M.J., Pascal G.A., Durand G.A. Dietary alpha-linolenic acid deficiency in adult rats for 7 months does not alter brain docosahexaenoic acid content, in contrast to liver, heart and testes. Biochim Biophys Acta 1992, 1124(2):119-122.
25. Levant B., Ozias M.K., Carlson S.E. Diet (n-3) polyunsaturated fatty acid content and parity affect liver and erythrocyte phospholipid fatty acid composition in female rats. J Nutr 2007, 137(11):2425-2430.
26. Holman R.T., Johnson S.B., Ogburn P.L. Deficiency of essential fatty acids and membrane fluidity during pregnancy and lactation. Proc Natl Acad Sci U S A 1991, 88(11):4835-4839.
27. Otto S.J., van Houwelingen A.C., Badart-Smook A., Hornstra G. Comparison of the peripartum and postpartum phospholipid polyunsaturated fatty acid profiles of lactating and nonlactating women. Am J Clin Nutr 2001, 73(6):1074-1079.
28. Stark K.D., Beblo S., Murthy M., Buda-Abela M., Janisse J., Rockett H., et al. Comparison of bloodstream fatty acid composition from African-American women at gestation, delivery, and postpartum. J Lipid Res 2005, 46(3):516-525.
29. Al M.D., van Houwelingen A.C., Hornstra G. Relation between birth order and the maternal and neonatal docosahexaenoic acid status. Eur J Clin Nutr 1997, 51(8):548-553.
30. Levant B., Ozias M.K., Davis P.F., Winter M., Russell K.L., Carlson S.E., et al. Decreased brain docosahexaenoic acid content produces neurobiological effects associated with depression: Interactions with reproductive status in female rats. Psychoneuroendocrinology 2008, 33(9):1279-1292.
31. Otto S.J., de Groot R.H., Hornstra G. Increased risk of postpartum depressive symptoms is associated with slower normalization after pregnancy of the functional docosahexaenoic acid status. Prostaglandins Leukot Essent Fatty Acids 2003, 69(4):237-243.
32. De Vriese S.R., Christophe A.B., Maes M. Lowered serum n-3 polyunsaturated fatty acid (PUFA) levels predict the occurrence of postpartum depression: further evidence that lowered n-PUFAs are related to major depression. Life Sci 2003, 73(25):3181-3187.
33. Hibbeln J.R. Seafood consumption, the DHA content of mothers' milk and prevalence rates of postpartum depression: a cross-national, ecological analysis. J Affect Disord 2002, 69(1-3):15-29.
34. Su K.P., Huang S.Y., Chiu T.H., Huang K.C., Huang C.L., Chang H.C., et al. Omega-3 fatty acids for major depressive disorder during pregnancy: results from a randomized, double-blind, placebo-controlled trial. J Clin Psychiatry 2008, 69(4):644-651.
35. Brunton P.J., Russell J.A. The expectant brain: adapting for motherhood. Nat Rev Neurosci 2008, 9(1):11-25.
36. Jolley S.N., Elmore S., Barnard K.E., Carr D.B. Dysregulation of the hypothalamic-pituitary-adrenal axis in postpartum depression. Biol Res Nurs 2007, 8(3):210-222.
37. Mastorakos G., Ilias I. Maternal and fetal hypothalamic-pituitary-adrenal axes during pregnancy and postpartum. Ann N Y Acad Sci 2003, 997:136-149.
38. Asher I., Kaplan B., Modai I., Neri A., Valevski A., Weizman A. Mood and hormonal changes during late pregnancy and puerperium. Clin Exp Obstet Gynecol 1995, 22(4):321-325.
39. Nissen E., Gustavsson P., Widstrom A.M., Uvnas-Moberg K. Oxytocin, prolactin, milk production and their relationship with personality traits in women after vaginal delivery or cesarean section. J Psychosom Obstet Gynaecol 1998, 19(1):49-58.
40. Arborelius L., Owens M.J., Plotsky P.M., Nemeroff C.B. The role of corticotropin-releasing factor in depression and anxiety disorders. J Endocrinol 1999, 160(1):1-12.
41. Hibbeln J.R., Bissette G., Umhau J.C., George D.T. Omega-3 status and cerebrospinal fluid corticotrophin releasing hormone in perpetrators of domestic violence. Biol Psychiatry 2004, 56(11):895-897.